BACKGROUND: Male circumcision can reduce the risk of heterosexually acquired HIV-1 infection in men. Neonatal male circumcision (NMC) has many potential advantages over circumcision at older ages, but little is known about its feasibility and safety in resource-limited settings. METHODS: We performed a randomized trial in southeastern Botswana of Mogen clamp and Plastibell, 2 commonly used devices for NMC. Follow-up visits occurred at 6 weeks and 4 months postpartum. Adverse events, parental satisfaction, and staff impressions were recorded. RESULTS: Of 302 male neonates randomized, 300 (99%) underwent circumcision, 153 (51%) with Mogen clamp, and 147 (49%) with Plastibell. There were no major adverse events in the Mogen clamp arm, but there were 2 major adverse events in the Plastibell arm (both were a proximally migrated ring that had to be removed by study staff). Minor adverse events were more common with the Mogen clamp compared with the Plastibell, specifically removal of too little skin and formation of skin bridges or adhesions (12 versus 1 and 11 versus 3, respectively, all P < 0.05). Five (3%) infants in the Mogen clamp arm and none in the Plastibell arm had minor bleeding (P = 0.03). More than 94% of mothers reported being highly or completely satisfied with the procedure. CONCLUSIONS:NMC can be performed in Botswana with a low rate of adverse events and high parental satisfaction. Although the risk of migration and retention of the Plastibell is small, the Mogen clamp may be safer for NMC in regions where immediate emergent medical attention is not available.
RCT Entities:
BACKGROUND: Male circumcision can reduce the risk of heterosexually acquired HIV-1 infection in men. Neonatal male circumcision (NMC) has many potential advantages over circumcision at older ages, but little is known about its feasibility and safety in resource-limited settings. METHODS: We performed a randomized trial in southeastern Botswana of Mogen clamp and Plastibell, 2 commonly used devices for NMC. Follow-up visits occurred at 6 weeks and 4 months postpartum. Adverse events, parental satisfaction, and staff impressions were recorded. RESULTS: Of 302 male neonates randomized, 300 (99%) underwent circumcision, 153 (51%) with Mogen clamp, and 147 (49%) with Plastibell. There were no major adverse events in the Mogen clamp arm, but there were 2 major adverse events in the Plastibell arm (both were a proximally migrated ring that had to be removed by study staff). Minor adverse events were more common with the Mogen clamp compared with the Plastibell, specifically removal of too little skin and formation of skin bridges or adhesions (12 versus 1 and 11 versus 3, respectively, all P < 0.05). Five (3%) infants in the Mogen clamp arm and none in the Plastibell arm had minor bleeding (P = 0.03). More than 94% of mothers reported being highly or completely satisfied with the procedure. CONCLUSIONS:NMC can be performed in Botswana with a low rate of adverse events and high parental satisfaction. Although the risk of migration and retention of the Plastibell is small, the Mogen clamp may be safer for NMC in regions where immediate emergent medical attention is not available.
Authors: Marisa R Young; Elijah Odoyo-June; Sherry K Nordstrom; Tracy E Irwin; Dedan O Ongong'a; Betha Ochomo; Kawango Agot; Robert C Bailey Journal: Pediatrics Date: 2012-06-18 Impact factor: 7.124
Authors: Ronald H Gray; Godfrey Kigozi; David Serwadda; Frederick Makumbi; Stephen Watya; Fred Nalugoda; Noah Kiwanuka; Lawrence H Moulton; Mohammad A Chaudhary; Michael Z Chen; Nelson K Sewankambo; Fred Wabwire-Mangen; Melanie C Bacon; Carolyn F M Williams; Pius Opendi; Steven J Reynolds; Oliver Laeyendecker; Thomas C Quinn; Maria J Wawer Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Robert C Bailey; Stephen Moses; Corette B Parker; Kawango Agot; Ian Maclean; John N Krieger; Carolyn F M Williams; Richard T Campbell; Jeckoniah O Ndinya-Achola Journal: Lancet Date: 2007-02-24 Impact factor: 79.321
Authors: Jacob Ben Chaim; Pinhas M Livne; Joseph Binyamini; Benyamin Hardak; David Ben-Meir; Yoram Mor Journal: Isr Med Assoc J Date: 2005-06 Impact factor: 0.892
Authors: Rebeca M Plank; Joseph Makhema; Poloko Kebaabetswe; Fatima Hussein; Chiapo Lesetedi; Daniel Halperin; Barbara Bassil; Roger Shapiro; Shahin Lockman Journal: AIDS Behav Date: 2010-10
Authors: Mert Ali Karadag; Kursat Cecen; Aslan Demir; Yuksel Kivrak; Murat Bagcioglu; Ramazan Kocaaslan; Mustafa Ari; Fatih Altunrende Journal: Can Urol Assoc J Date: 2015 Jan-Feb Impact factor: 1.862
Authors: Sten H Vermund; Sarah J Fidler; Helen Ayles; Nulda Beyers; Richard J Hayes Journal: J Acquir Immune Defic Syndr Date: 2013-07 Impact factor: 3.731
Authors: Godfrey Kigozi; Richard Musoke; Stephen Watya; Nehemia Kighoma; James Nkale; Mary Nakafeero; Dan Namuguzi; David Serwada; Fred Nalugoda; Nelson Sewankambo; Maria Joan Wawer; Ronald Henry Gray Journal: PLoS One Date: 2014-08-21 Impact factor: 3.240